Latest current assets for 4169.TW: $860M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (December 2025), 4169.TW shows a current assets of $860M. That compares with $810M in the prior-year period — up 5.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 4169.TW's current assets is now $860M (was $810M) — a 5.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether TCM Biotech International is outperforming or lagging.
Tracking 4169.TW's current assets over time shows whether TCM Biotech International is scaling, shrinking, or reshaping that part of the business. The current reading is $860M That compares with $810M in the prior-year period — up 5.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current assets page, Stockcircle has TCM Biotech International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $860M) with ownership activity and broader fundamentals.
TCM Biotech International's current assets is $860M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.